Heparin contraindications: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 5: | Line 5: | ||
Heparin sodium should not be used in patients: | Heparin sodium should not be used in patients: | ||
* With severe thrombocytopenia; | * With severe [[thrombocytopenia]]; | ||
* In whom suitable blood-coagulation tests (the whole-blood clotting time, [[partial thromboplastin time]], etc.) cannot be performed at appropriate intervals (this contraindication refers to full-dose Heparin; there is usually no need to monitor coagulation parameters in patients receiving low-dose Heparin); | |||
* With an uncontrollable active bleeding state, except when this is due to [[disseminated intravascular coagulation]]. | |||
{{FDA}} | {{FDA}} | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
Revision as of 21:28, 15 February 2009
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Contraindications
Heparin sodium should not be used in patients:
- With severe thrombocytopenia;
- In whom suitable blood-coagulation tests (the whole-blood clotting time, partial thromboplastin time, etc.) cannot be performed at appropriate intervals (this contraindication refers to full-dose Heparin; there is usually no need to monitor coagulation parameters in patients receiving low-dose Heparin);
- With an uncontrollable active bleeding state, except when this is due to disseminated intravascular coagulation.
Adapted from the FDA Package Insert.